SCTX

Scribe Therapeutics Inc. Common Stock

17.36

USD

+0.68

+4.08%

Nov 10, 15:59 UTC -5

Closed

After-Market

17.35

-0.01

-0.06%

Scribe Therapeutics Inc. Common Stock (SCTX) Profile

Scribe Therapeutics Inc. Common Stock Profile

About

Scribe Therapeutics Inc. is a clinical-stage biotechnology company engineering CRISPR-based technologies into purpose-built in vivo genetic medicines designed to become standard of care treatments for patients suffering from highly prevalent diseases, starting with cardiometabolic disease. Scribe Therapeutics Inc. is based in ALAMEDA, Calif.

Info & Links

CEO

Headquarters

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

Auditor

Share holders

Employees

Scribe Therapeutics Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

328.46M

Enterprise Value

330.68M

Enterprise Value/EBITDA(ttm)

-46.17

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

50.00%

Operating Margin(ttm)

Profit Margin(ttm)

-278.64%

Return on Equity(ttm)

Return on Invested Capital(ttm)

14.56%

Return on Assets(ttm)

Income Statement

Revenue(ttm)

4.15M

Revenue Per Share(ttm)

0.22

Gross Profit(ttm)

4.15M

EBITDA(ttm)³

-7.16M

Net Income Available to Common(ttm)

-23.82M

Diluted EPS(ttm)

Share Statistics

Beta (5Y Monthly)

52-Week Change

S&P 500 52-Week Change

16.37%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

18.93M

Dividend Yield

0.00%

Float⁴

0.00

% Held by Insiders

% Held by Institutions

Balance Sheet

Total Cash(mrq)

43.01M

Total Cash Per Share(mrq)

2.27

Total Debt(mrq)

37.80M

Total Debt/Equity(mrq)

-84.96%

Current Ratio(mrq)

0.57%

Quick Ratio(mrq)

0.57%

Book Value Per Share(mrq)

-17.90

Cash Flow

Operating Cash Flow Per Share(ytd)

-5.21

Free Cash Flow(ytd)

-12.92M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.